Editorial
Antiangiogenic therapy in cancer: a new era has begun
- PMID: 16100843
Item in Clipboard
Editorial
Antiangiogenic therapy in cancer: a new era has begun
Oncology (Williston Park).
2005 Apr.
Free article
No abstract available
Similar articles
-
Antiangiogenic agents in cancer therapy.Oncology (Williston Park). 2005 Apr;19(4 Suppl 3):17-25. Oncology (Williston Park). 2005. PMID: 15934499 Review.
-
Antiangiogenic therapy for cancer: current and emerging concepts.Oncology (Williston Park). 2005 Apr;19(4 Suppl 3):7-16. Oncology (Williston Park). 2005. PMID: 15934498 Review.
-
Clinical implications of antiangiogenic therapies.Oncology (Williston Park). 2005 Apr;19(4 Suppl 3):26-31. Oncology (Williston Park). 2005. PMID: 15934500 Review.
-
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.Biochem Biophys Res Commun. 2005 Jul 29;333(2):328-35. doi: 10.1016/j.bbrc.2005.05.132. Biochem Biophys Res Commun. 2005. PMID: 15961063 Review.
-
Current overview of angiogenesis inhibitors.Clin Adv Hematol Oncol. 2004 Aug;2(8):494-6, 520. Clin Adv Hematol Oncol. 2004. PMID: 16163228 No abstract available.
Cited by
-
Cytokine orchestration in post-operative peritoneal adhesion formation.World J Gastroenterol. 2008 Aug 21;14(31):4861-6. doi: 10.3748/wjg.14.4861. World J Gastroenterol. 2008. PMID: 18756592 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
